Skip to main content
Log in

Usefulness of esophagogastroduodenoscopy and 18F-fluorodeoxyglucose positron-emission tomography in detecting synchronous multiple primary cancers with oral cancer

  • Original Article
  • Published:
Oral and Maxillofacial Surgery Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study is to compare the value of screening for synchronous multiple primary cancers in other organs by esophagogastroduodenoscopy (EGD) or 18F-fluorodeoxyglucose positron-emission tomography (PET-CT) in patients newly diagnosed with oral cancer.

Methods

We retrospectively examined consecutive Japanese patients who were diagnosed with oral squamous cell carcinoma (OSCC) and were screened for synchronous multiple primary cancers in other organs by EGD and/or PET-CT between January 2010 and December 2015 at our institution. The study included 190 patients (106 males and 84 females) from 36 to 93 years of age (median age 68.8 years). The patients were screened by EGD, PET-CT, or both before beginning treatment for OSCC.

Results

Of 190 Japanese patients with OSCC, 15 had multiple primary cancers: 13 patients had double cancer and two had triple cancers. The sites of the 17 multiple primary cancers were gastric (6), esophageal (4), and lung (3), and ovarian, colon, liver, and thyroid (1 each). All of the gastric and esophageal cancers were found by EGD and were not detected by PET-CT. For three patients, the detection of multiple cancers affected the treatment modality or order of treatment selected for the OSCC. In two cases, the oral cancer and multiple primary cancer(s) in another organ were resected simultaneously by joint surgical teams.

Conclusions

PET-CT for oral cancer patients is an effective supporting diagnostic tool. However, the ability of PET-CT has some limitations. Especially for early detection of the upper gastrointestinal cancers, it is necessary to be supplemented by EGD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Crosher R, McIlroy R (1998) The incidence of other primary tumours in patients with oral cancer in Scotland. Br J Oral Maxillofac Surg 36(1):58–62

    Article  CAS  PubMed  Google Scholar 

  2. Fukuzawa K, Noguchi Y, Yoshikawa T, Saito A, Doi C, Makino T, Takanashi Y, Ito T, Tsuburaya A (1999) High incidence of synchronous cancer of the oral cavity and the upper gastrointestinal tract. Cancer Lett 144(2):145–151

    Article  CAS  PubMed  Google Scholar 

  3. Xu GZ, Guan DJ, He ZY (2011) (18)FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer. A meta-analysis. Oral Oncol 47(7):560–565. https://doi.org/10.1016/j.oraloncology.2011.04.021

    Article  PubMed  Google Scholar 

  4. Senft A, Hoekstra OS, Witte BI, Leemans CR, de Bree R (2016) Screening for distant metastases in head and neck cancer patients using FDG-PET and chest CT: validation of an algorithm. Eur Arch Oto-rhino-laryngology : Off J Eur Fed Oto-Rhino-Laryngological Soc 273(9):2643–2650. https://doi.org/10.1007/s00405-015-3773-8

    Article  Google Scholar 

  5. Stokkel MP, Terhaard CH, Hordijk GJ, van Rijk PP (1999) The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography. Eur J Nucl Med 26(7):767–773

    Article  CAS  PubMed  Google Scholar 

  6. Lapela M, Eigtved A, Jyrkkio S, Grenman R, Kurki T, Lindholm P, Nuutinen J, Sutinen E, Solin O, Bjornskov I, Bretlau P, Friberg L, Holm S, Jensen M, Sand Hansen H, Minn H (2000) Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer. Eur J Cancer 36(7):858–867

    Article  CAS  PubMed  Google Scholar 

  7. Krabbe CA, Pruim J, Dijkstra PU, Balink H, van der Laan BF, de Visscher JG, Roodenburg JL (2009) 18F-FDG PET as a routine posttreatment surveillance tool in oral and oropharyngeal squamous cell carcinoma: a prospective study. J Nucl Med: Off Publ, Soc Nucl Med 50(12):1940–1947. https://doi.org/10.2967/jnumed.109.065300

    Article  Google Scholar 

  8. Uyl-de Groot CA, Senft A, de Bree R, Leemans CR, Hoekstra OS (2010) Chest CT and whole-body 18F-FDG PET are cost-effective in screening for distant metastases in head and neck cancer patients. J Nucl Med: Off Publ Soc Nucl Med 51(2):176–182. https://doi.org/10.2967/jnumed.109.067371

    Article  Google Scholar 

  9. Charvat H, Sasazuki S, Inoue M, Iwasaki M, Sawada N, Shimazu T, Yamaji T, Tsugane S, Group JS (2016) Prediction of the 10-year probability of gastric cancer occurrence in the Japanese population: the JPHC study cohort II. Int J Cancer 138(2):320–331. https://doi.org/10.1002/ijc.29705

    Article  CAS  PubMed  Google Scholar 

  10. Shimada H, Okazumi S, Koyama M, Murakami K (2011) Japanese gastric cancer association task force for research promotion: clinical utility of (1)(8)F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature. Gastric Cancer 14(1):13–21. https://doi.org/10.1007/s10120-011-0017-5

    Article  PubMed  Google Scholar 

  11. Shoda H, Kakugawa Y, Saito D, Kozu T, Terauchi T, Daisaki H, Hamashima C, Muramatsu Y, Moriyama N, Saito H (2007) Evaluation of 18F-2-deoxy-2-fluoro-glucose positron emission tomography for gastric cancer screening in asymptomatic individuals undergoing endoscopy. Br J Cancer 97(11):1493–1498. https://doi.org/10.1038/sj.bjc.6604062

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Terauchi T, Murano T, Daisaki H, Kanou D, Shoda H, Kakinuma R, Hamashima C, Moriyama N, Kakizoe T (2008) Evaluation of whole-body cancer screening using 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography: a preliminary report. Ann Nucl Med 22(5):379–385. https://doi.org/10.1007/s12149-008-0130-7

    Article  PubMed  Google Scholar 

  13. Minamimoto R, Senda M, Jinnouchi S, Terauchi T, Yoshida T, Inoue T (2014) Performance profile of a FDG-PET cancer screening program for detecting gastric cancer: results from a nationwide Japanese survey. Jpn J Radiol 32(5):253–259. https://doi.org/10.1007/s11604-014-0294-0

    Article  CAS  PubMed  Google Scholar 

  14. Sohn YJ, Jang JS, Choi SR, Kwon HC, Jung GJ, Kim MC, Jeong JS (2009) Early detection of recurrence after endoscopic treatment for early gastric cancer. Scand J Gastroenterol 44(9):1109–1114. https://doi.org/10.1080/00365520903121701

    Article  PubMed  Google Scholar 

  15. Tsujimoto H, Sugasawa H, Ono S, Ichikura T, Yamamoto J, Hase K (2010) Has the accuracy of preoperative diagnosis improved in cases of early-stage gastric cancer? World J Surg 34(8):1840–1846. https://doi.org/10.1007/s00268-010-0587-0

    Article  PubMed  Google Scholar 

  16. Schmidt T, Lordick F, Herrmann K, Ott K (2015) Value of functional imaging by PET in esophageal cancer. J Natl Compr Cancer Netw 13(2):239–247

    Article  Google Scholar 

  17. Su YY, Chen WC, Chuang HC, Guo CS, Lin YT, Luo SD, Fang FM, Chien CY (2013) Effect of routine esophageal screening in patients with head and neck cancer. JAMA Otolaryngology-- head & neck surgery 139(4):350–354. https://doi.org/10.1001/jamaoto.2013.46

    Article  Google Scholar 

  18. Wang WL, Lee CT, Lee YC, Hwang TZ, Wang CC, Hwang JC, Tai CM, Chang CY, Tsai SS, Wang CP, Ko JY, Lin JT (2011) Risk factors for developing synchronous esophageal neoplasia in patients with head and neck cancer. Head Neck 33(1):77–81. https://doi.org/10.1002/hed.21397

    Article  CAS  PubMed  Google Scholar 

  19. Lim H, Kim DH, Jung HY, Gong EJ, Na HK, Ahn JY, Kim MY, Lee JH, Choi KS, Choi KD, Song HJ, Lee GH, Kim JH (2015) Clinical significance of early detection of esophageal cancer in patients with head and neck cancer. Gut Liver 9(2):159–165. https://doi.org/10.5009/gnl13401

    Article  CAS  PubMed  Google Scholar 

  20. Stokkel MP, Moons KG, ten Broek FW, van Rijk PP, Hordijk GJ (1999) 18F-fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer. Cancer 86(11):2370–2377

    Article  CAS  PubMed  Google Scholar 

  21. Krabbe CA, Pruim J, van der Laan BF, Rodiger LA, Roodenburg JL (2009) FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT. Oral Oncol 45(3):234–240. https://doi.org/10.1016/j.oraloncology.2008.05.024

    Article  PubMed  Google Scholar 

  22. Orlacchio A, Ciarrapico AM, Schillaci O, Chegai F, Tosti D, D'Alba F, Guazzaroni M, Simonetti G (2014) PET-CT in oncological patients: analysis of informal care costs in cost-benefit assessment. Radiol Med 119(4):283–289. https://doi.org/10.1007/s11547-013-0340-5

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Naomi Ishibashi-Kanno.

Ethics declarations

Conflicts of interests

None

Ethical approval

This ethical approval was obtained from the ethics board at the institution where the study was performed.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ishibashi-Kanno, N., Yamagata, K., Uchida, F. et al. Usefulness of esophagogastroduodenoscopy and 18F-fluorodeoxyglucose positron-emission tomography in detecting synchronous multiple primary cancers with oral cancer. Oral Maxillofac Surg 21, 391–396 (2017). https://doi.org/10.1007/s10006-017-0644-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10006-017-0644-z

Keywords

Navigation